David Butler
43Patents
15h-index
73Co-inventors
80Inventor score
Filing activity: Sep 23, 2005 → May 12, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9345780B2 | Site specific delivery of nucleic acids by combining targeting ligands with endosomolytic components | Chemistry; Metallurgy | 237 | Active |
| US8883202B2 | Lipid compositions | Emerging Cross-Sectional Technologies | 95 | Active |
| US8999351B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 91 | Active |
| US9982257B2 | Chiral control | Chemistry; Metallurgy | 63 | Active |
| US9605019B2 | Methods for the synthesis of functionalized nucleic acids | Chemistry; Metallurgy | 62 | Active |
| US8575123B2 | Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components | Chemistry; Metallurgy | 52 | Active |
| US10450568B2 | Oligonucleotide compositions and methods thereof | Chemistry; Metallurgy | 49 | Active |
| US8722082B2 | Lipids and compositions for the delivery of therapeutics | Chemistry; Metallurgy | 37 | Active |
| US9682139B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 28 | Active |
| US9220683B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 23 | Active |
| US8962580B2 | Chemical modifications of monomers and oligonucleotides with cycloaddition | Emerging Cross-Sectional Technologies | 22 | Active |
| US10160969B2 | Chiral design | Chemistry; Metallurgy | 21 | Active |
| US10280192B2 | Methods for the synthesis of functionalized nucleic acids | Chemistry; Metallurgy | 19 | Active |
| US10590413B2 | Chiral control | Chemistry; Metallurgy | 17 | Active |
| US10815482B2 | Chiral design | Chemistry; Metallurgy | 16 | Active |
| US11013757B2 | Oligonucleotides, compositions and methods thereof | Chemistry; Metallurgy | 14 | Active |
| US9687550B2 | Compositions for nucleic acid delivery | Chemistry; Metallurgy | 12 | Active |
| US9999673B2 | PEGylated lipids and their use for drug delivery | Chemistry; Metallurgy | 11 | Active |
| US10117941B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 10 | Active |
| US9764036B2 | Lipids and compositions for the delivery of therapeutics | Emerging Cross-Sectional Technologies | 7 | Active |
| US10456473B2 | Lipid compositions | Emerging Cross-Sectional Technologies | 6 | Active |
| US11603532B2 | Oligonucleotide compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US11407775B2 | Compositions and methods for phosphoramidite and oligonucleotide synthesis | Chemistry; Metallurgy | 5 | Active |
| US11597927B2 | Oligonucleotide compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US11718638B2 | Compounds, compositions and methods for synthesis | Chemistry; Metallurgy | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.